Evidence map›Paper›PMID 40229887›Full record

ArticleFluids and barriers of the CNS2025

Reactive astrocyte-derived exosomes enhance intracranial lymphatic drainage in mice after intracranial hemorrhage.

Kexin Li, Yuheng Liu, Junjie Gong, Jing Li, Mingyu Zhao, Chengyou Hong, Yuchi Zhang, Mengyao He, Zhenye Zhu, Zhijuan Chen and 1 more

Abstract read
In one paragraph

Article in Fluids and barriers of the CNS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Meningeal lymphatic dysfunction drives cognitive impairment after experimental subarachnoid hemorrhage.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Kexin Li *Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin, China.
Yuheng Liu *Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin, China.
Junjie GongDepartment of Neurosurgery, Tianjin Medical University General Hospital, Tianjin, China.
Jing LiDepartment of Neurosurgery, Tianjin Medical University General Hospital, Tianjin, China.
Mingyu ZhaoDepartment of Neurosurgery, Tianjin Medical University General Hospital, Tianjin, China.
Chengyou HongDepartment of Neurosurgery, Tianjin Medical University General Hospital, Tianjin, China.
Yuchi ZhangDepartment of Neurosurgery, Tianjin Medical University General Hospital, Tianjin, China.
Mengyao HeDepartment of Neurosurgery, Tianjin Medical University General Hospital, Tianjin, China.
Zhenye ZhuDepartment of Neurosurgery, Tianjin Medical University General Hospital, Tianjin, China.
Zhijuan ChenDepartment of Neurosurgery, Tianjin Medical University General Hospital, Tianjin, China. hapzhijuan0217@126.com.
Zengguang WangDepartment of Neurosurgery, Tianjin Medical University General Hospital, Tianjin, China. wzgforrest@163.com.

Funding

Tianjin Education Commission Research Program Project 2024KJ164Tianjin Health Commission Science and Technology Key Discipline Project TJWJ2024XK001
6 · The paper itself

Abstract

backgroundAfter intracranial hemorrhage (ICH), the formation of primary hematoma foci leads to the development of secondary brain injury factors such as perihematomal edema (PHE) and accumulation of toxic metabolites, which severely affect the survival and prognosis of patients. The intracerebral lymphatic system, proposed by Jeffrey J. Iliff et al., plays an important role in central nervous system (CNS) fluid homeostasis and waste removal, while reactive astrocyte-derived exosomes have shown therapeutic potential in CNS disorders. Our study focuses on the effects of hemin-treated reactive astrocyte-derived exosomes on the functional integrity of the glymphatic system (GLS) after ICH and their potential mechanism of action in repairing brain injury.

methodsHemin, an iron-rich porphyrin compound, was used to construct the in vitro model of ICH. Primary astrocytes were treated with complete medium supplemented with different concentrations of hemin to obtain exosomes secreted by them, and mice with ICH induced by the collagenase method were intervened by intranasal administration. Solute clearance efficiency was assessed by intracranial injection of cerebrospinal fluid tracers and fluorescent magnetic beads. Immunofluorescence analysis of Aquaporin 4 (AQP4) polarization and astrocyte proliferation. Magnetic Resonance Imaging was used to visualize and quantify the volume of hematoma foci and PHE, and Western Blot was used to analyze the accumulation of toxic metabolites, while neuronal apoptosis was detected by a combination of TUNEL assay apoptosis detection kit and Nissl staining, and their functional status was analyzed. Gait analysis software was used to detect functional recovery of the affected limb in mice.

resultsExosomes from hemin treated astrocytes facilitated the recovery of AQP4 polarization and attenuated astrocyte proliferation around hematoma foci in mice with ICH, thereby promoting the recovery of the GLS. Meanwhile, exosomes from hemin treated astrocytes reduced PHE and toxic protein accumulation, decreased apoptosis of cortical neurons on the affected side, and facilitated recovery of motor function of the affected limb, and these effects were blocked by TGN020, an AQP4-specific inhibitor.

conclusionsExosomes from hemin treated astrocytes attenuated secondary brain injury and neurological deficits in mice with ICH by promoting the repair of GLS injury.

Indexed as

AstrocytesBrain EdemaExosomesGlymphatic SystemIntracranial HemorrhagesAnimalsAquaporin 4Cells, CulturedDisease Models, AnimalHeminMaleMiceMice, Inbred C57BLAquaporin 4HeminAstrocyte-derived exosomesGlymphatic systemIntracranial hemorrhage

Identifiers

PMID40229887
PMCPMC11995599

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.